Market Capital
₹758 Cr.
P/E
10.73
Share Price
₹ 72.35 -0.4 (-0.55%)
Quick View
₹ 72.35 -0.4 (-0.55%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Company Timeline

Forensics
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a discount to 3yr historic valuations
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Revenue Recognition
Chances of aggressive revenue recognition - Operating profit of company is not getting converted to cash and recievables rising faster than sales
Share price
Share price has increased over last 10 years but more due to rerating
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been selling the stock which is usually a good time to buy
ROE
Latest
1.84%
3yr Average
7.84%
5yr Average
10.73%
Net Profit Margin
Latest
2.01%
3yr Average
9.33%
5yr Average
9.79%
ROCE
Latest
15.13%
3yr Average
15.57%
5yr Average
21.9%
Debt to Equity
Latest
0.13
3yr Average
0.15
5yr Average
0.16
Revenue mix

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Customers
    Company Filing
    Show Previous Years
    Discussions & Analysis